324.30
price down icon0.38%   -1.24
pre-market  Vorhandelsmarkt:  322.62   -1.68   -0.52%
loading
Schlusskurs vom Vortag:
$325.54
Offen:
$327.42
24-Stunden-Volumen:
2.38M
Relative Volume:
0.91
Marktkapitalisierung:
$174.63B
Einnahmen:
$35.89B
Nettoeinkommen (Verlust:
$7.01B
KGV:
25.07
EPS:
12.9352
Netto-Cashflow:
$11.54B
1W Leistung:
-1.78%
1M Leistung:
+2.06%
6M Leistung:
+9.83%
1J Leistung:
+20.03%
1-Tages-Spanne:
Value
$319.79
$327.75
1-Wochen-Bereich:
Value
$319.79
$343.05
52-Wochen-Spanne:
Value
$261.43
$346.38

Amgen Inc Stock (AMGN) Company Profile

Name
Firmenname
Amgen Inc
Name
Telefon
(805)447-1000
Name
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Mitarbeiter
28,000
Name
Twitter
@amgen
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
AMGN's Discussions on Twitter

Vergleichen Sie AMGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMGN
Amgen Inc
324.30 175.30B 35.89B 7.01B 11.54B 12.94
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,077.19 967.52B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
213.65 505.28B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
220.75 388.90B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
141.61 272.12B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
108.26 271.01B 63.90B 19.05B 13.05B 7.5596

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-01-07 Fortgesetzt UBS Buy
2025-12-05 Hochstufung Erste Group Hold → Buy
2025-11-24 Fortgesetzt Truist Hold
2025-11-13 Eingeleitet Scotiabank Sector Outperform
2025-09-03 Fortgesetzt Raymond James Mkt Perform
2025-05-20 Fortgesetzt Guggenheim Neutral
2025-04-22 Fortgesetzt Cantor Fitzgerald Neutral
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-17 Eingeleitet Bernstein Outperform
2024-10-14 Herabstufung Truist Buy → Hold
2024-09-27 Eingeleitet Cantor Fitzgerald Overweight
2024-08-07 Herabstufung Wells Fargo Overweight → Equal Weight
2024-05-03 Hochstufung Barclays Underweight → Equal Weight
2024-05-03 Hochstufung William Blair Mkt Perform → Outperform
2024-03-28 Fortgesetzt Raymond James Mkt Perform
2024-02-07 Herabstufung Leerink Partners Outperform → Market Perform
2023-12-21 Hochstufung Daiwa Securities Neutral → Buy
2023-12-19 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-12-12 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-02 Hochstufung Truist Hold → Buy
2023-10-20 Fortgesetzt JP Morgan Neutral
2023-10-17 Fortgesetzt Morgan Stanley Equal-Weight
2023-10-11 Fortgesetzt BofA Securities Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-04-24 Bestätigt Oppenheimer Outperform
2023-03-13 Hochstufung Wells Fargo Equal Weight → Overweight
2023-02-13 Bestätigt Truist Buy
2022-11-18 Eingeleitet Credit Suisse Underperform
2022-10-31 Herabstufung Barclays Equal Weight → Underweight
2022-10-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-05-23 Eingeleitet SVB Leerink Mkt Perform
2022-02-09 Bestätigt Barclays Equal Weight
2022-02-09 Bestätigt Jefferies Buy
2022-02-09 Bestätigt Morgan Stanley Equal-Weight
2022-02-09 Bestätigt Oppenheimer Outperform
2022-02-09 Bestätigt Wells Fargo Equal Weight
2022-01-05 Herabstufung BofA Securities Buy → Neutral
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Buy
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-09-23 Herabstufung Daiwa Securities Outperform → Neutral
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-29 Eingeleitet Daiwa Securities Buy
2020-10-28 Eingeleitet UBS Neutral
2020-10-26 Hochstufung Raymond James Mkt Perform → Outperform
2020-10-12 Hochstufung Truist Hold → Buy
2020-10-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-10-09 Herabstufung Truist Buy → Hold
2020-10-08 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-15 Fortgesetzt Guggenheim Neutral
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-03-30 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-05 Hochstufung BofA/Merrill Neutral → Buy
2020-02-27 Eingeleitet Barclays Equal Weight
2020-01-31 Herabstufung Robert W. Baird Neutral → Underperform
2020-01-21 Hochstufung Evercore ISI In-line → Outperform
2019-12-24 Eingeleitet Raymond James Mkt Perform
2019-12-17 Fortgesetzt Morgan Stanley Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-11-05 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-19 Herabstufung Mizuho Buy → Neutral
2019-05-23 Hochstufung Citigroup Neutral → Buy
Alle ansehen

Amgen Inc Aktie (AMGN) Neueste Nachrichten

pulisher
Jan 13, 2026

Decliners Report: Why Amgen Inc stock could rally in 20252025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - moha.gov.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen Growth Story Isn't Tapped Out Yet, Says Goldman - Benzinga

Jan 13, 2026
pulisher
Jan 13, 2026

Ro partners with Amgen to study barriers to obesity care, GLP-1 access - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen at the Crossroads: MariTide, Market Volatility, and the Quest for Obesity Dominance - FinancialContent

Jan 13, 2026
pulisher
Jan 13, 2026

Ro announces research collaboration with Amgen to evaluate real-world GLP-1 coverage - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen (AMGN) Reveals Promising Results from MariTide Phase 2 Stu - GuruFocus

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen Inc. $AMGN Shares Acquired by PKO Investment Management Joint Stock Co - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Nordea Investment Management AB Acquires 22,465 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Trickle of Data On Amgen’s MariTide Hints At Potential Of Lower Maintenance Dosing - Citeline News & Insights

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen to announce data on obesity drug MariTide at healthcare conference - WNWN-FM

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen Inc. $AMGN Shares Bought by Citizens Financial Group Inc. RI - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Amgen says MariTide helped trial patients maintain weight loss - The Mighty 790 KFGO

Jan 13, 2026
pulisher
Jan 13, 2026

AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules - BioSpace

Jan 13, 2026
pulisher
Jan 12, 2026

Amgen Calls 2026 a “Springboard Year” as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen’s MariTide Patients Maintain Weight Loss for Two Years - Bloomberg.com

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen's Maritide: A Breakthrough in Diabetes Management - Devdiscourse

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen's MariTide phase 2 study shows 'meaningful' reduction in blood sugar, weight - TradingView — Track All Markets

Jan 12, 2026
pulisher
Jan 12, 2026

Key Executive Transition from Amgen (AMGN) to BioMarin - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen Fights Regeneron’s Bid to Pause Eylea Antitrust Claims - Bloomberg Law News

Jan 12, 2026
pulisher
Jan 12, 2026

Lobbying Update: $37,500 of AMGEN INC. lobbying was just disclosed - Quiver Quantitative

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen Inc. $AMGN Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Meeder Asset Management Inc. Purchases 27,584 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Tema Etfs LLC Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

First Horizon Corp Takes Position in Amgen Inc. $AMGN - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Amgen Buys U.K. Biotech Company - Los Angeles Business Journal

Jan 12, 2026
pulisher
Jan 11, 2026

How Amgen’s DISCO Oncology Licensing Deal Will Impact Amgen (AMGN) Investors - simplywall.st

Jan 11, 2026
pulisher
Jan 11, 2026

Amgen Stock Holds Its Ground: What The Latest Price Action, Ratings and Pipeline Signals Mean For In - AD HOC NEWS

Jan 11, 2026
pulisher
Jan 10, 2026

Amgen stock slides into weekend as JPMorgan healthcare conference looms - TechStock²

Jan 10, 2026
pulisher
Jan 10, 2026

Nepsis Inc. Cuts Stock Position in Amgen Inc. $AMGN - MarketBeat

Jan 10, 2026
pulisher
Jan 09, 2026

Is It Time To Reassess Amgen (AMGN) After Its 28% One Year Share Price Gain? - Yahoo Finance

Jan 09, 2026
pulisher
Jan 09, 2026

Amgen to acquire Dark Blue for cancer drug DBT 3757 - BioXconomy

Jan 09, 2026
pulisher
Jan 09, 2026

State of Alaska Department of Revenue Sells 3,034 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Oregon Public Employees Retirement Fund Buys 15,172 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Amgen Inc. $AMGN Shares Sold by Nova R Wealth Inc. - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% - Investing.com

Jan 09, 2026
pulisher
Jan 09, 2026

Amgen (NASDAQ:AMGN) Stock Rating Upgraded by UBS Group - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Amgen Inc. $AMGN Shares Bought by Ferguson Wellman Capital Management Inc. - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Amgen Inc. (NASDAQ:AMGN) aligns with nasdaq composite life sciences - Kalkine Media

Jan 09, 2026
pulisher
Jan 09, 2026

Can Amgen Inc. stock rebound after recent weaknessQuarterly Earnings Report & Technical Pattern Based Signals - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com

Jan 08, 2026
pulisher
Jan 08, 2026

How Amgen Inc. stock valuations compare to rivalsWeekly Profit Report & Growth Oriented Trading Recommendations - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Amgen (AMGN) Valuation Check After DISCO Oncology Deal And Fresh Analyst Optimism - simplywall.st

Jan 08, 2026
pulisher
Jan 08, 2026

Amgen (NASDAQ:AMGN) Price Target Raised to $319.00 at Truist Financial - MarketBeat

Jan 08, 2026
pulisher
Jan 08, 2026

Goldman Sachs Adjusts Price Target on Amgen to $403 From $400, Maintains Buy Rating - MarketScreener

Jan 08, 2026
pulisher
Jan 08, 2026

Amgen Advances Leukemia Strategy With Completed Blinatumomab Study in Japan - TipRanks

Jan 08, 2026
pulisher
Jan 08, 2026

Should Amgen’s (AMGN) Exclusive DISCO Oncology Deal Require Action From Investors? - Yahoo Finance

Jan 08, 2026
pulisher
Jan 08, 2026

Amgen acquires British Dark Blue Therapeutics for USD 840m - medwatch.com

Jan 08, 2026
pulisher
Jan 08, 2026

SG Americas Securities LLC Has $79.95 Million Stake in Amgen Inc. $AMGN - MarketBeat

Jan 08, 2026
pulisher
Jan 08, 2026

Amgen Inc. $AMGN Shares Acquired by HB Wealth Management LLC - MarketBeat

Jan 08, 2026
pulisher
Jan 08, 2026

Evotec benefits from Dark Blue acquisition by Amgen - European Biotechnology Magazine

Jan 08, 2026

Finanzdaten der Amgen Inc-Aktie (AMGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$121.76
price down icon 0.69%
drug_manufacturers_general PFE
$25.15
price down icon 0.47%
drug_manufacturers_general SNY
$47.20
price down icon 0.84%
drug_manufacturers_general NVO
$59.64
price down icon 0.37%
drug_manufacturers_general MRK
$108.26
price down icon 0.85%
Kapitalisierung:     |  Volumen (24h):